NCT01284387 Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01282619 Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease Status UNKNOWN Phase PHASE2/PHASE3
NCT01264614 Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older Adults Status COMPLETED Phase NA
NCT01258452 Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects Status COMPLETED Phase PHASE1
NCT01255163 A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT01254773 Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01254448 Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01251718 Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease Status COMPLETED Phase N/A
NCT01249196 A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT01238991 Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT01238458 Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy Volunteers Status UNKNOWN Phase PHASE2
NCT01230853 A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study Status COMPLETED Phase PHASE1
NCT01227564 Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01227252 A Safety Study of LY2886721 Multiple Doses in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01224106 A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT01221259 A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01217541 Collaboration Between Department of Old Age Psychiatry and Nursing Homes Status COMPLETED Phase NA
NCT01211782 AC-1204 Long-term Efficacy Response Trial (ALERT Protocol) Status WITHDRAWN Phase PHASE2/PHASE3